Clinical Study
Statin as a Combined Therapy for Advanced-Stage Ovarian Cancer: A Propensity Score Matched Analysis
Table 1
Baseline characteristics of statin users (
) and matched nonstatin users (
).
| Characteristics | Statin users number (%) | Matched nonstatin users number (%) | |
| Age | | 68.16 ± 7.50 | | <65 years | 13 (43.3) | 12 (40) | 1 | ≥ 65 | 17 (56.7) | 18 (60) | FIGO stage | | | | III | 17 (56.7) | 19 (63.3) | 0.792 | IV | 13 (43.3) | 11 (36.7) | Tumor grade | | | | G1-G2 | 9 (30) | 4 (13.3) | 0.209 | G3 | 21 (70) | 26 (86.7) | Histological subtype | | | | Epithelial | 4 (13.3) | 6 (20) | 0.731 | Nonepithelial | 26 (93.3) | 24 (80) | Cytoreductive surgery | | | | Residual tumor > 1 cm | 13 (43.3) | 14 (46.7) | 0.888 | Residual tumor ≤ 1 cm | 14 (46.7) | 14 (46.7) | Not recorded | 3 (10) | 2 (6.7) | Cycles of chemotherapy | | | | ≥6 cycles | 27 (90) | 25 (83.3) | 0.331 | Not recorded | 2 (6.7) | 1 (3.3) | Comorbidities | | | | Hypercholesterolemia | 21 (70) | 21 (70) | 1 | Cardiovascular diseases | 10 (33.3) | 10 (33.3) | 1 |
|
|